ARTICLE | Company News
CSPC gains Chinese rights to I-Mab's GLP-1
December 21, 2018 7:30 PM UTC
TG103, a long-acting glucagon-like peptide-1 (GLP-1), is in Phase I testing in Germany....
BCIQ Target Profiles
TG103, a long-acting glucagon-like peptide-1 (GLP-1), is in Phase I testing in Germany....
BCIQ Target Profiles
BCIQ Target Profiles